Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Comment by Walterthedogon Nov 17, 2020 6:19pm
93 Views
Post# 31919189

RE:Revenue Q1

RE:Revenue Q1I wouldn't expect 1.6M$ as much as I hate to say it. Our dried sales are declining, since Q2 (although up in Q4 from Q3) and the price per gram seems to be as well. I figure we sold at most 200 000$ worth of KISS Q1 so I would expect around 1M$ or hopefully a little more with a similar real loss of around 250 000$. Not the end of the world but not giving anyone a b0ner either. Hopefully I'm wrong about KISS sales and they should increase over time as wholesalers get a better read on how fast they sell. I think like someone else said on here, the shots (although delicious and the effects are awesome) are kind of a novelty item and won't be replacing beers anytime soon. We really need them to nail it with the 200 ml cans for taste and please for gods sake Miller, get a designer to make the can not suck. 3mg is actually perfect for a light weight like me. One KISS shot and I'm pretty god damn high. Then if it tastes good (hopefully like something more identifiable than herbal water) and we are the lowest priced drink around, they should sell well too. Everyone has chocolates and gummies which is why i was not impressed by that idea but Miller says he plans on beating everyone else on price. On BC cannabis store they seem to have a price floor on edibles of 3.99$ but We've proven that you can drop your price to whatever on OCS which has access to almost half of Canadas population. Anyways it's not a bad strategy and I hope for some small scale winning next year.
<< Previous
Bullboard Posts
Next >>